+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nuclear Magnetic Resonance Spectroscopy Market Size, Share & Trends Analysis Report By Type (Low-field, High-field), By Products (Instruments, Consumables), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5649410
The global nuclear magnetic resonance spectroscopy market size is expected to reach USD 1.08 billion by 2030, according to a new report. The market is anticipated to expand at a CAGR of 5.1% from 2024 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW-Madison's National Magnetic Resonance Facility at Madison.

Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market's growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.

The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.

The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson's disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.

On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost.

Nuclear Magnetic Resonance Spectroscopy Market Report Highlights

  • By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
  • The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
  • By type, the high-field NMR spectroscopy segment dominated the market in 2023, since it offers better sensitivity to the researchers
  • By end-use, the academic segment held a larger share in 2023; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
  • North America held a substantial share in the global market in 2023 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
  • The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product and type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Nuclear Magnetic Resonance Spectroscopy Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Development Of Generic Drugs / API
3.2.1.2. Acceleration In Biomedical Research
3.2.1.3. Increasing Metabolomics-Based Diagnosis
3.2.2. Market Restraint Analysis
3.2.2.1. Expensive Equipment And Maintenance At Low Sensitivity
3.2.2.2. The Presence Of Interfering Substances Disrupts The Research
3.3. Nuclear Magnetic Resonance Spectroscopy Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Key Stakeholders in the NMR Spectroscopy Market
Chapter 4. Nuclear Magnetic Resonance Spectroscopy Market: Product Estimates & Trend Analysis
4.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Dashboard
4.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
4.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Product, Revenue
4.4. Instruments
4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
4.5. Consumables
4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. Nuclear Magnetic Resonance Spectroscopy Market: Type Estimates & Trend Analysis
5.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Dashboard
5.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
5.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Type, Revenue
5.4. Low-field NMR Spectroscopy
5.4.1. Low-field NMR spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)
5.5. High-field NMR spectroscopy
5.5.1. High-field NMR Spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. Nuclear Magnetic Resonance Spectroscopy Market: End Use Estimates & Trend Analysis
6.1. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Dashboard
6.2. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Movement Analysis
6.3. Global Nuclear Magnetic Resonance Spectroscopy Market by End Use, Revenue
6.4. Academic
6.4.1. Academic market estimates and forecasts 2018 - 2030 (USD Million)
6.5. Pharmaceutical and Biotech Companies
6.5.1. Pharmaceutical and biotech companies market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Agriculture and Food
6.6.1. Agriculture and food market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Chemical Industry
6.7.1. Chemical industry market estimates and forecasts 2018 - 2030 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Nuclear Magnetic Resonance Spectroscopy Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
7.4.6. Denmark
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
7.5.4. South Korea
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
7.5.6. Singapore
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
7.5.7. Thailand
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
7.6.2. Mexico
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. JEOL Ltd.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Thermo Fisher Scientific Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Bruker
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Magritek
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Oxford Instruments
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Nanalysis Corp.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Anasazi Instruments, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. QOneTec
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Advanced Magnetic Resonance Limited
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 4 Global Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 5 Global Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 6 Global Nuclear Magnetic Resonance Spectroscopy, by Region, 2018 - 2030 (USD Million)
Table 7 North America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
Table 8 North America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 9 North America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 10 North America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 11 U.S. Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 12 U.S. Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 13 U.S. Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 14 Canada Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 15 Canada Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 16 Canada Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 17 Europe Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 19 Europe Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 20 Europe Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 21 Germany Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 22 Germany Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 23 Germany Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 24 UK Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 25 UK Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 26 UK Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 27 France Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 28 France Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 29 France Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 30 Italy Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 31 Italy Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 32 Italy Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 33 Spain Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 34 Spain Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 35 Spain Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 36 Denmark Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 37 Denmark Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 38 Denmark Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 39 Sweden Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 40 Sweden Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 41 Sweden Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 42 Norway Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 43 Norway Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 44 Norway Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 45 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 49 China Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 50 China Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 51 China Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 52 Japan Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 53 Japan Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 54 Japan Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 55 India Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 56 India Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 57 India Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 58 South Korea Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 59 South Korea Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 60 South Korea Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 61 Australia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 62 Australia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 63 Australia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 64 Singapore Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 65 Singapore Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 66 Singapore Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 67 Thailand Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 68 Thailand Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 69 Thailand Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 70 Latin America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
Table 71 Latin America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 72 Latin America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 73 Latin America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 74 Brazil Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 75 Brazil Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 76 Brazil Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 77 Mexico Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 78 Mexico Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 79 Mexico Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 80 Argentina Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 81 Argentina Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 82 Argentina Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 86 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 87 South Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 88 South Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 89 South Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 90 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 91 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 92 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 93 UAE Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 94 UAE Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 95 UAE Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
Table 96 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
Table 97 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
Table 98 Kuwait Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Nuclear Magnetic Resonance Spectroscopy Market Segmentation
Fig. 8 Market Snapshot, 2023
Fig. 9 Market Trends & Outlook
Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 14 Porter’s Five Forces Analysis
Fig. 15 Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
Fig. 16 Global Nuclear Magnetic Resonance Spectroscopy Market, for Instruments, 2018 - 2030 (USD Million)
Fig. 17 Global Nuclear Magnetic Resonance Spectroscopy Market, for Consumables, 2018 - 2030 (USD Million)
Fig. 18 Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
Fig. 19 Global Nuclear Magnetic Resonance Spectroscopy Market, for Low-field NMR Spectroscopy, 2018 - 2030 (USD Million)
Fig. 20 Global Nuclear Magnetic Resonance Spectroscopy Market, for High-field NMR Spectroscopy, 2018 - 2030 (USD Million)
Fig. 21 Global Nuclear Magnetic Resonance Spectroscopy Market: End-use Movement Analysis
Fig. 22 Global Nuclear Magnetic Resonance Spectroscopy Market, for Academic, 2018 - 2030 (USD Million)
Fig. 23 Global Nuclear Magnetic Resonance Spectroscopy Market, for Pharmaceutical and Biotech Companies, 2018 - 2030 (USD Million)
Fig. 24 Global Nuclear Magnetic Resonance Spectroscopy Market, for Agriculture and Food, 2018 - 2030 (USD Million)
Fig. 25 Global Nuclear Magnetic Resonance Spectroscopy Market, for Chemical Industry, 2018 - 2030 (USD Million)
Fig. 26 Global Nuclear Magnetic Resonance Spectroscopy Market, for Others, 2018 - 2030 (USD Million)
Fig. 27 Regional Marketplace: Key Takeaways
Fig. 28 Regional Outlook, 2023 & 2030
Fig. 29 Global Nuclear Magnetic Resonance Spectroscopy Market: Region Movement Analysis
Fig. 30 North America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 31 U.S. Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 32 Canada Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 33 Europe Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 34 Germany Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 35 UK Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 36 France Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 37 Italy Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 38 Spain Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 39 Denmark Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 40 Sweden Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 41 Norway Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 43 Japan Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 44 China Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 45 India Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 46 Australia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 47 South Korea Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 48 Singapore Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 49 Thailand Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 50 Latin America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 51 Brazil Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 52 Mexico Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 53 Argentina Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 55 South Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 57 UAE Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • JEOL LTD.
  • THERMO FISHER SCIENTIFIC INC.
  • BRUKER
  • MAGRITEK
  • OXFORD INSTRUMENTS
  • NANALYSIS CORP.
  • ANASAZI INSTRUMENTS, INC.
  • QONETEC
  • ADVANCED MAGNETIC RESONANCE LIMITED

Methodology

Loading
LOADING...

Table Information